Xconomy

JANUARY 4, 2019

In 2018, geopolitical events—in particular, President Donald Trump’s hard-line stances on trade and immigration, and the repeal of net neutrality rules—were top of mind for several business executives we interviewed recently. Xconomy: Has the Trump era been good or bad for your company?

San Diego 102

San Diego .Net Startup Develop 102

Xconomy

NOVEMBER 13, 2016

I started with a list of companies already screened by the San Diego Venture Group’s annual venture summit, and consulted with investors and startup mentors to refine the list. million in a Series D round of investment capital, according to founder and chairman Tony Farwell. I widened my net this year.

San Diego 40

San Diego Technical Review Artificial Inteligence Startup 40

Xconomy

JANUARY 15, 2019

Some leaders responded with their views on the business impact of the Trump era, pointing to specific policy positions such as tax code revisions, curbs on immigration, and the decision by federal regulators to roll back net neutrality requirements on telecom carriers.

.Net 65

.Net Technology Develop Development 65

Xconomy

AUGUST 8, 2016

It’s been less than a year since Needham, MA-based PTC (NASDAQ: PTC ) shelled out $65 million to acquire Vuforia, the augmented reality technology created by San Diego-based Qualcomm (NASDAQ: QCOM ). Vuforia’s headquarters has remained in San Diego, and Vuforia continues to operate four offices in Europe and Israel, Wright said.

San Diego 40

San Diego Mobile Examples .Net 40

Xconomy

JANUARY 11, 2017

Morgan healthcare investment conference in San Francisco, Saunders reiterated that the high single-digit price hikes would only bring Allergan (NYSE: AGN ) a two or three percent net increase in revenues after middlemen like Express Scripts (NYSE: ESRX ) and CVS Health (NYSE: CVS ), called pharmacy.

Pricing 40

Pricing .Net Conference Invest 40

Xconomy

AUGUST 26, 2016

—Cambridge-based startup Amylyx Pharmaceuticals raised a $5 million Series A round from Morningside Venture, the ALS Investment Fund, and former Genzyme CEO Henri Termeer to develop a drug meant to stop the death of nerve cells in patients with amyotrophic lateral sclerosis.

Pricing 40

Pricing Thousand Oaks Startup Research 40

Both Sides of the Table

JUNE 8, 2014

I’ve blogged about this before and provide a lot more details in these posts: 1. The problem that I’ve seen historically in cities like Los Angeles, San Diego or Seattle is that their historic high-net-worth individuals didn’t come from the tech startup world. We have invested $17.3

Startup 390

Startup Venture Capital Capital Funding 390